Yezan Munther Haddadin
Director · 2 filings · Latest: Jun 2, 2026
Outlook Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
OTLK | Yezan Munther Haddadin | Director | Jun 2, 2026 | Purchase | $0.8326 | 29,000 | $24.1K | 66,167 | |
OTLK | Yezan Munther Haddadin | Director | May 26, 2026 | Purchase | $0.44 | 34,000 | $15.0K | 37,167 | |